AbbVie (ABBV)
Develops immunology, neuroscience, oncology, and aesthetics products led by Skyrizi and Rinvoq.
$265.75
vs last close+1.27 (+0.48%)
Something off on this page? Send us feedback.
Dividend yield
2.58%
Next ex-date
Oct 15, 26
in 23 days
Annual dividend
$6.83
per share
Schedule
Quarterly
4 payments a year
Per share, Jan 2025 to Oct 2026DividendAnnual yieldUpcoming
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Dividend$1.64$1.64$1.64$1.64$1.73$1.73$1.73$1.73
Annual yield3.67%3.61%3.47%2.90%3.10%3.23%2.80%2.61%
Ex-dateJan 15Apr 15Jul 15Oct 15Jan 16Apr 15Jul 15Oct 15
Payment dateFeb 14May 15Aug 15Nov 14Feb 17May 15Aug 14Nov 16
20 payments since Oct 2021
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Oct 15, 2026 | Oct 15, 2026 | Nov 16, 2026 | $1.73 | upcoming |
| Jul 15, 2026 | Jul 15, 2026 | Aug 14, 2026 | $1.73 | |
| Apr 15, 2026 | Apr 15, 2026 | May 15, 2026 | $1.73 | |
| Jan 16, 2026 | Jan 16, 2026 | Feb 17, 2026 | $1.73 | raised from $1.64 |
| Oct 15, 2025 | Oct 15, 2025 | Nov 14, 2025 | $1.64 | |
| Jul 15, 2025 | Jul 15, 2025 | Aug 15, 2025 | $1.64 | |
| Apr 15, 2025 | Apr 15, 2025 | May 15, 2025 | $1.64 | |
| Jan 15, 2025 | Jan 15, 2025 | Feb 14, 2025 | $1.64 | raised from $1.55 |
| Oct 15, 2024 | Oct 15, 2024 | Nov 15, 2024 | $1.55 | |
| Jul 15, 2024 | Jul 15, 2024 | Aug 15, 2024 | $1.55 | |
| Apr 12, 2024 | Apr 15, 2024 | May 15, 2024 | $1.55 | |
| Jan 12, 2024 | Jan 16, 2024 | Feb 15, 2024 | $1.55 | raised from $1.48 |
| Oct 12, 2023 | Oct 13, 2023 | Nov 15, 2023 | $1.48 | |
| Jul 13, 2023 | Jul 14, 2023 | Aug 15, 2023 | $1.48 | |
| Apr 13, 2023 | Apr 14, 2023 | May 15, 2023 | $1.48 | |
| Jan 12, 2023 | Jan 13, 2023 | Feb 15, 2023 | $1.48 | raised from $1.41 |
| Oct 13, 2022 | Oct 14, 2022 | Nov 15, 2022 | $1.41 | |
| Jul 14, 2022 | Jul 15, 2022 | Aug 15, 2022 | $1.41 | |
| Apr 13, 2022 | Apr 15, 2022 | May 16, 2022 | $1.41 | |
| Jan 13, 2022 | Jan 14, 2022 | Feb 15, 2022 | $1.41 | raised from $1.30 |
| Oct 14, 2021 | Oct 15, 2021 | Nov 15, 2021 | $1.30 |